epoxiconazole has been researched along with transforming growth factor alpha in 1 studies
| Studies (epoxiconazole) | Trials (epoxiconazole) | Recent Studies (post-2010) (epoxiconazole) | Studies (transforming growth factor alpha) | Trials (transforming growth factor alpha) | Recent Studies (post-2010) (transforming growth factor alpha) |
|---|---|---|---|---|---|
| 122 | 0 | 99 | 4,301 | 44 | 623 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hester, S; Moore, T; Murphy, L; Nesnow, S; Padgett, WT; Wood, CE | 1 |
1 other study(ies) available for epoxiconazole and transforming growth factor alpha
| Article | Year |
|---|---|
The hepatocarcinogenic conazoles: cyproconazole, epoxiconazole, and propiconazole induce a common set of toxicological and transcriptional responses.
Topics: Administration, Oral; Animals; Carcinogens; Cell Proliferation; Chemical and Drug Induced Liver Injury; Dose-Response Relationship, Drug; Epoxy Compounds; Fungicides, Industrial; Gene Expression Regulation, Neoplastic; Hepatocytes; Liver; Male; Mice; Mice, Inbred Strains; Oligonucleotide Array Sequence Analysis; Transforming Growth Factor alpha; Triazoles | 2012 |